Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy: A Breast International Group (BIG) 1-98 sub-analyses.

被引：0
|
作者：
Leone, Jose Pablo
Cole, Bernard F.
Regan, Meredith M.
Thurlimann, Beat J. K.
Coates, Alan S.
Goldhirsch, Aron
Di Leo, Angelo
Colleoni, Marco
Luis, Ines Maria Vaz Duarte
Lin, Nancy U.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Vermont, Burlington, VT USA
[3] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA
[4] Kantonsspital, St Gallen, Switzerland
[5] Univ Sydney, Sydney, NSW, Australia
[6] IBCSG Investigator, Bern, Switzerland
[7] SOLE Investigator, Bern, Switzerland
[8] Hosp Prato, Prato, Italy
[9] European Inst Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
538
引用
收藏
页数：1
相关论文
共 50 条
  • [31] BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer
    Mouridsen, H. T.
    Giobbie-Hurder, A.
    Mauriac, L.
    Paridaens, R.
    Colleoni, M.
    Thuerlimann, B.
    Forbes, J. F.
    Gelber, R. D.
    Wardley, A.
    Smith, I
    Price, K. N.
    Coates, A.
    Goldhirsch, A.
    CANCER RESEARCH, 2009, 69 (02) : 66S - 67S
  • [32] Central review of ER, PgR and HER-2 in BIG 1-98 evaluating letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer
    Viale, G
    Regan, M
    Dell'Orto, P
    Del Curto, B
    Braye, S
    Orosz, Z
    Brown, R
    Olszewski, WP
    Knox, F
    Oehlschlegel, C
    Thürlimann, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S13 - S14
  • [33] Adjuvant Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer in Premenopausal Patient: Understanding the Data
    Saha P.
    Fleming G.F.
    Current Breast Cancer Reports, 2015, 7 (4) : 183 - 189
  • [34] Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
    Kensler, Kevin H.
    Regan, Meredith M.
    Heng, Yujing J.
    Baker, Gabrielle M.
    Pyle, Michael E.
    Schnitt, Stuart J.
    Hazra, Aditi
    Kammler, Roswitha
    Thurlimann, Beat
    Colleoni, Marco
    Viale, Giuseppe
    Brown, Myles
    Tamimi, Rulla M.
    BREAST CANCER RESEARCH, 2019, 21 (1)
  • [35] Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)
    Kolben, Thomas
    Engelmann, Susanne
    Maurer, Susanne
    Kolben, Martin
    BREAST CARE, 2012, 7 (01) : 39 - 44
  • [36] Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
    Ruhstaller, Thomas
    Giobbie-Hurder, Anita
    Colleoni, Marco
    Jensen, Maj-Britt
    Ejlertsen, Bent
    de Azambuja, Evandro
    Neven, Patrick
    Lang, Istvan
    Jakobsen, Erik Hugger
    Gladieff, Laurence
    Bonnefoi, Herve
    Harvey, Vernon J.
    Spazzapan, Simon
    Tondini, Carlo
    Del Mastro, Lucia
    Veyret, Corinne
    Simoncini, Edda
    Gianni, Lorenzo
    Rochlitz, Christoph
    Kralidis, Elena
    Zaman, Khalil
    Jassem, Jacek
    Piccart-Gebhart, Martine
    Di Leo, Angelo
    Gelber, Richard D.
    Coates, Alan S.
    Goldhirsch, Aron
    Thuerlimann, Beat
    Regan, Meredith M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (02) : 105 - +
  • [37] Inflammatory response to neoadjuvant endocrine therapy in hormone receptor-positive breast cancer
    Oner, G.
    Van Berckelaer, C.
    Praet, M.
    Canturk, N. Z.
    Altintas, S.
    Tjalma, W.
    Berneman, Z.
    Peeters, M.
    Pauwels, P.
    van Dam, P. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 79 - 80
  • [38] BIG 1-98: A prospective randomized double-blind double-dummy phase III study to evaluate letrozole as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer
    BREAST, 2005, 14 : S3 - S3
  • [39] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    中华医学杂志英文版, 2020, 133 (19) : 2338 - 2345
  • [40] American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
    Burstein, Harold J.
    Prestrud, Ann Alexis
    Seidenfeld, Jerome
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen E.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Malin, Jennifer
    Mamounas, Eleftherios P.
    Rowden, Diana
    Solky, Alexander J.
    Sowers, MaryFran R.
    Stearns, Vered
    Winer, Eric P.
    Somerfield, Mark R.
    Griggs, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3784 - 3796
12345